Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Reexamination Certificate
2008-04-24
2010-06-08
Wang, Andrew (Department: 1656)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
C435S252300, C435S252330, C435S254100, C435S320100, C536S023200, C536S023400
Reexamination Certificate
active
07732182
ABSTRACT:
The invention provides isolated nucleic acids molecules, designated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 gene has been introduced or disrupted. The invention still further provides isolated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 proteins, fusion proteins, antigenic peptides and anti-25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
REFERENCES:
patent: 5854067 (1998-12-01), Newgard et al.
patent: 5891717 (1999-04-01), Newgard et al.
patent: 6673549 (2004-01-01), Furness et al.
patent: 6727066 (2004-04-01), Kaser
patent: 7070947 (2006-07-01), Meyers et al.
patent: 7193069 (2007-03-01), Isogai et al.
patent: 7411054 (2008-08-01), Meyers et al.
patent: 2002/0009779 (2002-01-01), Meyers et al.
patent: 2003/0211093 (2003-11-01), Yue et al.
patent: WO 97/26357 (1997-07-01), None
Schwab, D.A., et al., 1988, “The complete amino acid sequence of the catalytic domain of rat brain hexokinase, deduced from the cloned cDNA” The Journal of Biological Chemistry, vol. 263, No. 7, pp. 3220-3224.
Arora, K.K., et al., 1990, Glucose phosphorylation in tumor cells. Cloning, sequencing, and overexpression in active form of a full-length murine cDNA encoding a mitochondrial bindable form of hexokinase, The Journal of Biological Chemistry, vol. 265, No. 11, pp. 6481-6488.
Aleshin, A.E., et al., 1998, “The mechanism of regulation of hexokinase: new insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate”, Structure, vol. 6, No. 1, pp. 39-50.
Murakami, K., et al., 1998, “The erythrocyte-specific hexokinase isozyme (HKR) and the common hexokinase isozyme (HKI) are produced from a single gene by alternate promoters”, Blood, vol. 90, pp. 272-272 [Abstract 1198].
Altschul et al., J. Mol. Biol., 1990, 215:403-410.
Altschul et al.,Nucleic Acids Res., 1997, 25(17):3389-3402.
Karlin et al.,Proc. Natl. Acad. Sci. USA, 1990, 87(6):2264-2268.
Karlin et al.,Proc. Natl. Acad. Sci. USA, 1993, 90(12):5873-5877.
Myers et al.,CABIOS. 1988, 4:11-17.
Sonnhammer et al.,Proteins, 1997, 28(3):405-420.
GenBank Accession No. AK026414; Suzuki, Submitted Aug. 29, 2000.
Deeb et al., “Human Hexokinase II: Sequence and Homology to other Hexokinases”,Biochem. and Biophys. Res. Comm., 197:68-74 (1993).
EMBL Accession No. AI949849, Mar. 14, 2000.
EMBL Accession No. BE159085, Dias Neto et al., Jul. 2, 2000.
EMBL Accession No. AW475040, Mar. 2, 2000.
Katabi et al., “Hexokinase Type II: A Novel Tumor-Specific Promoter for Gene-Targeted Therapy Differentially Expressed and Regularted in Human Cancer Celles”,Human Gene Therapy, 10:155-164 (1999).
Mathupala et al., “Arrest of proliferation of highly glycolytic tumors upon Type II hexokinase down regulation via an antisense RNA approach”, Proceedings of the American Association for Cancer Research, 40:22 (1999).
Meyers Rachel E.
Williamson Mark J.
Millennium Pharmaceuticals Inc.
Moore William W
Wang Andrew
LandOfFree
25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4189701